Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution
 Back to Details

connectionMarilyn Lilun Moy, M.D.

Co-Authors

This is a "connection" page, showing publications co-authored by Marilyn Moy and Eric Garshick.

 
Connection Strength
  
 
 
4.421
  
  1. Moy ML, Teylan M, Weston NA, Gagnon DR, Danilack VA, Garshick E. Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD. Chest. 2014 Mar 01; 145(3):542-550.
    View in: PubMed
    Score: 0.787
  2. Moy ML, Teylan M, Danilack VA, Gagnon DR, Garshick E. An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014 Feb; 11(2):149-57.
    View in: PubMed
    Score: 0.783
  3. Moy ML, Teylan M, Weston NA, Gagnon DR, Garshick E. Daily step count predicts acute exacerbations in a US cohort with COPD. PLoS One. 2013; 8(4):e60400.
    View in: PubMed
    Score: 0.739
  4. Moy ML, Danilack VA, Weston NA, Garshick E. Daily step counts in a US cohort with COPD. Respir Med. 2012 Jul; 106(7):962-9.
    View in: PubMed
    Score: 0.692
  5. Moy ML, Matthess K, Stolzmann K, Reilly J, Garshick E. Free-living physical activity in COPD: assessment with accelerometer and activity checklist. J Rehabil Res Dev. 2009; 46(2):277-86.
    View in: PubMed
    Score: 0.550
  6. Garshick E, Laden F, Hart JE, Moy ML. Respiratory symptoms and intensity of occupational dust exposure. Int Arch Occup Environ Health. 2004 Oct; 77(7):515-20.
    View in: PubMed
    Score: 0.408
  7. Moy ML, Janney AW, Nguyen HQ, Matthess KR, Cohen M, Garshick E, Richardson CR. Use of pedometer and Internet-mediated walking program in patients with chronic obstructive pulmonary disease. J Rehabil Res Dev. 2010; 47(5):485-96.
    View in: PubMed
    Score: 0.147
  8. Moy ML, Reilly JJ, Ries AL, Mosenifar Z, Kaplan RM, Lew R, Garshick E. Multivariate models of determinants of health-related quality of life in severe chronic obstructive pulmonary disease. J Rehabil Res Dev. 2009; 46(5):643-54.
    View in: PubMed
    Score: 0.138
  9. Moy ML, Garshick E, Matthess KR, Lew R, Reilly JJ. Accuracy of uniaxial accelerometer in chronic obstructive pulmonary disease. J Rehabil Res Dev. 2008; 45(4):611-7.
    View in: PubMed
    Score: 0.128
  10. Maron BA, Goldstein RH, Rounds SI, Shapiro S, Jankowich M, Garshick E, Moy ML, Gagnon D, Choudhary G. Study design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment of pulmonary hypertension due to chronic obstructive lung disease: the TADA-PHiLD (TADAlafil for Pulmonary Hypertension associated with chronic obstructive Lung Disease) trial. Pulm Circ. 2013 Dec; 3(4):889-97.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.